Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Taylor

Showing results (181-190 of 206) with videos related to

Pageof 21
Sort By:
International Journal of Cancer|June 19, 1991
Altered expression of P-glycoprotein and cellular adhesion molecules on human multi-drug-resistant tumor cells does not affect their susceptibility to NK- and LAK-mediated cytotoxicityR J Scheper, W S Dalton, T M Grogan, et al.
Physiological Chemistry and Physics|January 1, 1972
Homology of the amino terminal sequences of the AL and GAR calf thymus histonesM O Olson, N Sugano, L C Yeoman, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 1997
Amifostine protects normal tissues from paclitaxel toxicity while cytotoxicity against tumour cells is maintainedC W Taylor, L M Wang, A F List, et al.
Biochemistry|October 23, 1997
Disaccharide polyphosphates based upon adenophostin A activate hepatic D-myo-inositol 1,4,5-trisphosphate receptorsJ S Marchant, M D Beecroft, A M Riley, et al.
Circulation Research|February 7, 2001
Crucial role of type 1, but not type 3, inositol 1,4,5-trisphosphate (IP(3)) receptors in IP(3)-induced Ca(2+) release, capacitative Ca(2+) entry, and proliferation of A7r5 vascular smooth muscle cellsY Wang, J Chen, Y Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1990
Treatment of small-cell lung cancer with an alternating chemotherapy regimen given at weekly intervals: a Southwest Oncology Group pilot studyC W Taylor, J Crowley, S K Williamson, et al.
Journal of Medicinal Chemistry|September 1, 2000
Synthesis of potent agonists of the D-myo-inositol 1,4, 5-trisphosphate receptor based on clustered disaccharide polyphosphate analogues of adenophostin AM de Kort, V Correa, A R Valentijn, et al.
Blood|December 1, 1992
Long-term engraftment of fresh human myeloma cells in SCID miceF J Feo-Zuppardi, C W Taylor, K Iwato, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|April 1, 1992
A Southwest Oncology Group Phase I study of the sequential combination of recombinant interferon-gamma and recombinant interleukin-2 in patients with cancerC W Taylor, E M Chase, R P Whitehead, et al.
British Journal of Cancer|June 1, 1991
Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell lineC W Taylor, W S Dalton, P R Parrish, et al.
Pageof 21

Showing results (181-190 of 206) with videos related to

Sort By:
Pageof 21
International Journal of Cancer|June 19, 1991
Altered expression of P-glycoprotein and cellular adhesion molecules on human multi-drug-resistant tumor cells does not affect their susceptibility to NK- and LAK-mediated cytotoxicityR J Scheper, W S Dalton, T M Grogan, et al.
Physiological Chemistry and Physics|January 1, 1972
Homology of the amino terminal sequences of the AL and GAR calf thymus histonesM O Olson, N Sugano, L C Yeoman, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 1997
Amifostine protects normal tissues from paclitaxel toxicity while cytotoxicity against tumour cells is maintainedC W Taylor, L M Wang, A F List, et al.
Biochemistry|October 23, 1997
Disaccharide polyphosphates based upon adenophostin A activate hepatic D-myo-inositol 1,4,5-trisphosphate receptorsJ S Marchant, M D Beecroft, A M Riley, et al.
Circulation Research|February 7, 2001
Crucial role of type 1, but not type 3, inositol 1,4,5-trisphosphate (IP(3)) receptors in IP(3)-induced Ca(2+) release, capacitative Ca(2+) entry, and proliferation of A7r5 vascular smooth muscle cellsY Wang, J Chen, Y Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1990
Treatment of small-cell lung cancer with an alternating chemotherapy regimen given at weekly intervals: a Southwest Oncology Group pilot studyC W Taylor, J Crowley, S K Williamson, et al.
Journal of Medicinal Chemistry|September 1, 2000
Synthesis of potent agonists of the D-myo-inositol 1,4, 5-trisphosphate receptor based on clustered disaccharide polyphosphate analogues of adenophostin AM de Kort, V Correa, A R Valentijn, et al.
Blood|December 1, 1992
Long-term engraftment of fresh human myeloma cells in SCID miceF J Feo-Zuppardi, C W Taylor, K Iwato, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|April 1, 1992
A Southwest Oncology Group Phase I study of the sequential combination of recombinant interferon-gamma and recombinant interleukin-2 in patients with cancerC W Taylor, E M Chase, R P Whitehead, et al.
British Journal of Cancer|June 1, 1991
Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell lineC W Taylor, W S Dalton, P R Parrish, et al.
Pageof 21